FDA Supports DSS Suspension of Sowore's Prosecution

The Foundation for Democracy in Africa (FDA) has expressed approval of the Department of State Services (DSS) decision, led by Director-General Oluwatosin Adeola Ajayi, to suspend the prosecution of Omoyele Sowore, the presidential candidate of the African Action Congress (AAC), until after the 2027 presidential election. The FDA characterized this decision as a commitment to democracy, due process, and the integrity of the electoral process.
In a statement signed on Tuesday by Secretary Comrade Daniel Elachi Omaga and Co-convener Comrade Isah Abubakar, the FDA argued that no presidential candidate should face procedural disadvantages due to pending criminal cases during an election period. They noted that the decision aligns with regional and international democratic principles.
The FDA commended Ajayi for his commitment to due process since taking office in August 2024, including the release of wrongfully detained individuals and reliance on judicial processes. They clarified that the suspension does not exempt Sowore from legal accountability and that prosecution could resume post-election.
Plus234Feed summary based on reporting from Nigerian Tribune. Read the original report below.
Read full article
Continue on Nigerian Tribune
Enjoy this article?
Get the weekly Nigerian roundup — top stories, NPFL, naira. One email, Sunday morning.
Related Stories

FDA Backs DSS Decision to Pause Sowore's Prosecution

NAPS Supports DSS's Suspension of Sowore's Prosecution

AAC Demands Withdrawal of Sowore's Prosecution by DSS

DSS Suspends Sowore's Cybercrime Case Until 2027 Election

Sowore Demands DSS Apology Over Cybercrime Trial Delay

Sowore Calls DSS Cybercrime Case Suspension a Victory
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.









